Asia-Pacific Journal of Oncology Nursing

EDITORIAL
Year
: 2021  |  Volume : 8  |  Issue : 6  |  Page : 594--595

MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer


Ji Ruan 
 Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

Correspondence Address:
Ji Ruan
Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou,
China




How to cite this article:
Ruan J. MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer.Asia Pac J Oncol Nurs 2021;8:594-595


How to cite this URL:
Ruan J. MET Inhibitor is Expected to Overcome MET Amplification-Induced Immunotherapy Resistance in Non-Small Cell Lung Cancer. Asia Pac J Oncol Nurs [serial online] 2021 [cited 2021 Nov 29 ];8:594-595
Available from: https://www.apjon.org/article.asp?issn=2347-5625;year=2021;volume=8;issue=6;spage=594;epage=595;aulast=Ruan;type=0